Dishman Carbogen Amcis Limited
DCAL
Rank in Stocks
#15172
Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen... Established in 1983 and headquartered in Ahmedabad, India, Dishman Carbogen Amcis Limited provides specialized contract research and manufacturing solutions to the worldwide pharmaceutical sector. The company operates through two main business segments: Contract Research and Manufacturing Services (CR&MS), and Marketable Molecules. Beyond its core services, it manufactures and distributes an extensive portfolio of products, including bulk drugs, chemical intermediates, various phase transfer catalysts, quaternary ammonium compounds, phosphoranes, wittig reagents, vitamin D derivatives, and fine chemicals. Additionally, its offerings encompass personal care products like hand and body washes, sanitizers, and antiseptics, as well as a range of pharmaceutical and cosmetic formulations, including generic and highly potent active pharmaceutical ingredients. Dishman Carbogen Amcis Limited is a subsidiary of Adimans Technologies LLP.
Share Price
$1.78
Last synced: 2026-11-09
Market Cap
$278.86M
Change (1 day)
7.26%
Change (1 year)
-36.24%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Dishman Carbogen Amcis Limited (DCAL)
Category
Healthcare
EPS for Dishman Carbogen Amcis Limited (DCAL)
EPS as of June 2026 TTM: $0.05
According to Dishman Carbogen Amcis Limited's latest financial reports, its current EPS (TTM) is $0.05. At the end of 2025 the company had an EPS of 0.00, an increase over its 2024 EPS of $-0.12.
EPS history for Dishman Carbogen Amcis Limited from 2005 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $0.05 | -102.13% |
| 2025 | 0.00 | -102.13% |
| 2024 | $-0.12 | 408.23% |
| 2023 | $-0.02 | -252.98% |
| 2022 | $0.02 | -110.50% |
| 2021 | $-0.14 | -210.02% |
| 2020 | $0.13 | -30.33% |
| 2019 | $0.19 | 27.53% |
| 2018 | $0.15 | 5.90% |
| 2017 | $0.14 | -13.19% |
| 2016 | $0.16 | 34.34% |
| 2015 | $0.12 | 5.49% |
| 2014 | $0.11 | -1.40% |
| 2013 | $0.11 | 64.99% |
| 2012 | $0.07 | -37.65% |
| 2011 | $0.11 | -31.34% |
| 2010 | $0.16 | -9.29% |
| 2009 | $0.18 | -8.92% |
| 2008 | $0.20 | 29.25% |
| 2007 | $0.15 | 82.67% |
| 2006 | $0.08 | 51.09% |
| 2005 | $0.06 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $15.66 | 34,166.96% |
US
|
|
| $-7.07 | -15,570.46% |
US
|
|
| $-5.29 | -11,675.49% |
AU
|
|
| $12.88 | 28,084.03% |
BE
|
|
| $21.56 | 47,077.24% |
NL
|
Questions about Dishman Carbogen Amcis Limited's earnings per share (EPS)
What is Dishman Carbogen Amcis Limited's earnings per share (EPS)?
Dishman Carbogen Amcis Limited's earnings per share (EPS) over the last twelve months is $0.05, as of Jun 2026.
What was Dishman Carbogen Amcis Limited's earnings per share (EPS) in 2025?
In 2025, Dishman Carbogen Amcis Limited's earnings per share (EPS) was 0.00, compared with $-0.12 in 2024.
How has Dishman Carbogen Amcis Limited's earnings per share (EPS) changed since 2020?
From 2020 to 2025, Dishman Carbogen Amcis Limited's earnings per share (EPS) was highest in 2020 ($0.13) and lowest in 2021 ($-0.14).
How does Dishman Carbogen Amcis Limited's earnings per share (EPS) compare with similar companies?
Dishman Carbogen Amcis Limited's earnings per share (EPS) ($0.05) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.